| Delicious |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Arts and Entertainment > Humor > Joe Lieberman Loses Democratic Primary; Republicans Celebrate |
|
Delicious - Joe Lieberman Loses Democratic Primary; Republicans Celebrate
Poor Joe Lieberman – how fallen from grace is he and in such a sudden way. Just six years ago, the Democratic candidate for Vice President, today he finds himself unable to persuade his party to ree According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product lect him to a fourth term in the Senate. And, as lousy luck would have it, he lost the Democratic primary just days before the disruption of the horrific terrorist plan to detonate ten passenger-pa ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ked planes flying between London and New York. Had that interruption happened before the election, it might have changed enough minds, since the electorate’s principal problem with Joe is his contin lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ing support of the war in Iraq. Undaunted in the face of rejection, Joe will go on as an independent candidate. As he undoubtedly consoles himself, even Lincoln had his setbacks but would not, in d here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe feat, retreat. While he will not, of course, have the Democratic machine behind him, but opposing him, he will have little competition for the Republican vote, which in Connecticut is even larger t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro an the Democratic one. Add his still faithful Democratic advocates, and he may well yet emerge the winner. Anticipating that longed-for outcome even now, he said, "I'm an independent Democrat, seek ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng the support of Democrats, Republicans and Independents in Connecticut. They're the ones that sent me to Washington three times before." The oddest turn of events is that what the Democrats celeb easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ated as victory, the Republicans, ever attuned to the slightest political haymaker, used Joe’s defeat to trumpet their election year reprise of the overdone theme, “Democrats are soft on defense.” nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ven Dick Cheney displayed some carefully calculated simpatico for the denied Democrat. “It’s an unfortunate development, I think, from the standpoint of the Democratic Party, to see a man like Liebe and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ man pushed aside because of his willingness to support an aggressive posture in terms of our national security strategy,’’ Mr. Cheney intoned disingenuously. Even the formerly mild-mannered Tony Sn ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi w got in his lick: “This is a defining moment in some ways for the Democratic Party. I know a lot of people have tried to make this a referendum on the president. I would flip it. I think instead it ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s a defining moment for the Democratic Party, whose national leaders now have made it clear that if you disagree with the extreme left in their party they’re going to come after you.” We ask in all dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod of this the most urgent question. In this political maelstrom is there at least one human being who elicits our interest and, in fact, our care? You guessed the candidate for the laudation. Jumpin’ cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ack Joe. Our interest is not based on whether or not he voted for the war in Iraq and continues to believe in its necessity. It’s because overall he is the kind of smart with heart person we need i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Washington, and such valuable people, in the role of politicos, come along all too rarely and then only one at a time. Oh, sure, he could have weaseled around his principals and said he recants hi t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel support of the war and the arch Republican Bush. But he demurred, saying, “I know that’s what they want me to do. But I’m not going to do it, because I don’t think it’s right.” How many of today’s ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust oliticians, or politicians from any other time, would stand on such moral high ground, despite the obvious harm to his candidacy, since the opponent who seemed to have the wider appeal of the moment y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products had based his entire campaign on an antiwar platform. We note that a lot of Connecticut voters still go for Joe. “Joe’s still the man for the job,” one said. “He’s used his power to do a lot of po . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de itive things.” Actually, while the Democratic machine, including Dean, the Clintons, and Schumer, went over to Lamont, only a handful of Lieberman supporters who were interviewed said they would sw elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tch to Mr. Lamont. So, while Joe has received a reprimand from his party faithful, it seems he may yet be on his way back to Washington on the Metroliner on which we ourselves have seen him shuttle tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Nokia 5300 and Samsung P310: Classy Phones Divorce Attorneys - Don't Get Stuck With a Dud Rinchenpong, The Place Where Heavens Descend
|